We hypothesize that the higher frequency of TP53-mutant breast cancer observed in early parous women could be explained by the fact that an early pregnancy could protect less effectively against TP53 mutant pre-malignant lesions (Fig. 4). The gene discussed is TP53; the disease is breast cancer.